Expertise in
1
conditions

Ingvil Mjaaland

Stavanger, NO 
Expertise in
1
conditions
Stavanger, NO 

Overview

Ingvil Mjaaland practices practicing medicine in Stavanger, Norway.

Mjaaland is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Breast Cancer, Pigmented Purpuric Dermatosis, and Mastectomy.

They are actively involved in clinical research, co-authoring 30 peer reviewed articles and participating in 1 clinical trial.

Locations

Stavanger, Norway
Other Locations
Norway
Oslo, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Radiation, Drug, Procedure
Study Drugs: Neoadjuvant Tamoxifen+Goserelin, Neoadjuvant Letrozole, Neoadjuvant Docetaxel+Cyclophosphamide, Neoadjuvant Docetaxel, Neoadjuvant Docetaxel+Trastuzumab+Pertuzumab, Neoadjuvant, Neoadjuvant Olaparib, Neoadjuvant Cyclophosphamide, Adjuvant Trastuzumab, Adjuvant Letrozole, Adjuvant Tamoxifen+Goserelin, Adjuvant Palbociclib, Adjuvant Epirubicin+Cyclophosphamide
Study Phase: Phase 2

30 Total Publications

Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1.
Hypo- Versus Standard Fractionated Locoregional Radiotherapy of Patients With High-Risk Breast Cancer in the Randomized Phase III Trial: The Danish Breast Cancer Group Skagen Trial 1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 23, 2026

Frequently Asked Questions about Ingvil Mjaaland

Is Ingvil Mjaaland a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ingvil Mjaaland is classified as an Advanced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ingvil Mjaaland participate in research or clinical trials?

Yes. Ingvil Mjaaland has published 30 articles and abstracts on conditions like Breast Cancer. You can view a list of Ingvil Mjaaland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mjaaland's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile